https://www.marketscreener.com/quote/stock/BIOTIME-INC-8471985/news/BioTime-Inc-BioTime-Successfully-Completes-HyStem-Rx-Preclinical-ISO-10993-Studies-13929709/?utm_source=telegram&utm_medium=social&utm_campaign=share